← Back to Treatments
🏅 FDA Orphan Designation

Acthrel

Corticorelin ovine triflutate

Manufacturer: Ferring Laboratories, Inc.

Indicated for:
OBSOLETE: ACTH-independent Cushing syndromeOrphanACTH-dependent Cushing syndrome

FDA-Approved Indications (2)

To differentiate between pituitary and ectopic production of ACTH in patients with ACTH-dependent Cushing's syndrome.

To differentiate between pituitary and ectopic production of ACTH in patients with ACTH-dependent Cushing's syndrome

Population: patients with ACTH-dependent Cushing's syndrome

Indications & Usage

To differentiate between pituitary and ectopic production of ACTH in patients with ACTH-dependent Cushing's syndrome.

💙 Support Programs

View all →
Acthrel
Ferring Laboratories, Inc.

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.